Back to search

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States

Data up to Jan 2025

Published2006
Citations424
References34
Clinical Trials (1)

Total Citations Per Year

Abstract

References (34)

Comorbidity Measures for Use with Administrative Data

1998 • 8,872 citations

Prevalence of Diagnosed Atrial Fibrillation in Adults

2001 • 6,106 citations

Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation

1995 • 2,148 citations

Smearing Estimate: A Nonparametric Retransformation Method

1983 • 1,991 citations

Lifetime Cost of Stroke in the United States

1996 • 823 citations

Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs

1998 • 686 citations

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

2004 • 585 citations

Secular trends in the prevalence of atrial fibrillation: The Framingham study

1996 • 454 citations

Nonparametric Statistics for Health Care Research: Statistics for Small Samples and Unusual Distributions

1998 • 404 citations

Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation

1995 • 329 citations

Analysis and implications

1988 • 268 citations

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database

2001 • 263 citations

Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986–1996

2001 • 170 citations

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.

1992 • 131 citations

Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation

1998 • 113 citations

Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001

2004 • 107 citations

Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care

1999 • 89 citations

Cost-Effectiveness of Transesophageal Echocardiographic-Guided Cardioversion: A Decision Analytic Model for Patients Admitted to the Hospital With Atrial Fibrillation

1997 • 76 citations

Cost-effectiveness analysis in heart disease, part III: Ischemia, congestive heart failure, and arrhythmias

1995 • 76 citations

Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation

1998 • 76 citations

Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study

2005 • 75 citations

Cost-Effectiveness of Anticoagulation in Nonrheumatic Atrial Fibrillation in the Primary Prevention of Ischemic Stroke

1998 • 75 citations

Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs

2003 • 75 citations

Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness Issues

1998 • 68 citations

Trends and Outcomes in the Hospitalization of Older Americans for Cardiac Conduction Disorders or Arrhythmias, 1991–1998

2001 • 67 citations

Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation

1999 • 66 citations

Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980–1999

2005 • 62 citations

Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome.

1993 • 60 citations

Reduction in medical care cost associated with radiofrequency catheter ablation of accessory pathways

1991 • 50 citations

Cost Analysis of a Managed Care Decentralized Outpatient Pharmacy Anticoagulation Service

2004 • 46 citations

Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK (Heart (2004) 90, (286-292))

2007 • 40 citations

Cost Comparison of Radiofrequency Modification and Ablation of the Atrioventricular Junction in Patients With Chronic Atrial Fibrillation

1997 • 32 citations

Second Line Pharmacological Management of Paroxysmal and Persistent Atrial Fibrillation in France: A Cost Analysis

2000 • 24 citations

Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter

2000 • 15 citations

Cited By (0)

Loading...
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United… (2006) – Value in Health | Metascience Observatory Explorer